Key facts
- It has raised $430.6M across 5 recorded rounds; the latest was PIPE ($150.0M) in Dec 2025.
- 2 institutional filers report fund marks on Vor Biopharma across 5 filings.
- Vor Biopharma has filed 1 Form D with the SEC, most recently Jul 2020 ($110.1M sold to 33 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Vor Biopharma
Create free account
No card required
Funding rounds
5 roundsDec 2025PIPE$150.0M▮
Jun 2025PIPE$175.0M▮
Dec 2024PIPE$55.5M▮
Dec 2022PIPE$50.0M▮
About Vor Biopharma
- Industry
- Drug Discovery
PA Mark — not yet priced
Vor Biopharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Vor Biopharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
2 filers · latest May 20262 SEC-registered funds reported 5 fair-value marks on Vor Biopharma between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.